HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Deficiency of carboxylesterase 1/esterase-x results in obesity, hepatic steatosis, and hyperlipidemia.

AbstractUNLABELLED:
Increased lipogenesis, together with hyperlipidemia and increased fat deposition, contribute to obesity and associated metabolic disorders including nonalcoholic fatty liver disease. Here we show that carboxylesterase 1/esterase-x (Ces1/Es-x) plays a regulatory role in hepatic fat metabolism in the mouse. We demonstrate that Ces1/Es-x knockout mice present with increased hepatic lipogenesis and with oversecretion of apolipoprotein B (apoB)-containing lipoproteins (hepatic very-low density lipoproteins), which leads to hyperlipidemia and increased fat deposition in peripheral tissues. Consequently, Ces1/Es-x knockout mice develop obesity, fatty liver, hyperinsulinemia, and insulin insensitivity on chow diet without change in food intake and present with decreased energy expenditure. Ces1/Es-x deficiency prevents the release of polyunsaturated fatty acids from triacylglycerol stores, leading to an up-regulation of sterol regulatory element binding protein 1c-mediated lipogenesis, which can be reversed with dietary ω-3 fatty acids.
CONCLUSION:
These studies support a role for Ces1/Es-x in the partitioning of regulatory fatty acids and concomitant control of hepatic lipid biosynthesis, secretion, and deposition.
AuthorsAriel D Quiroga, Lena Li, Martin Trötzmüller, Randy Nelson, Spencer D Proctor, Harald Köfeler, Richard Lehner
JournalHepatology (Baltimore, Md.) (Hepatology) Vol. 56 Issue 6 Pg. 2188-98 (Dec 2012) ISSN: 1527-3350 [Electronic] United States
PMID22806626 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2012 American Association for the Study of Liver Diseases.
Chemical References
  • Blood Glucose
  • Fatty Acids, Unsaturated
  • Fish Oils
  • Insulin
  • Lipoproteins, VLDL
  • Phospholipids
  • Sterol Regulatory Element Binding Protein 1
  • Triglycerides
  • Docosahexaenoic Acids
  • Cholesterol
  • Carboxylic Ester Hydrolases
  • carboxylesterase 1, mouse
Topics
  • Analysis of Variance
  • Animals
  • Blood Glucose (metabolism)
  • Carboxylic Ester Hydrolases (deficiency, genetics, metabolism)
  • Cholesterol (metabolism)
  • Docosahexaenoic Acids (metabolism)
  • Energy Metabolism
  • Fasting
  • Fatty Acids, Unsaturated (administration & dosage, metabolism)
  • Fatty Liver (enzymology, genetics)
  • Female
  • Fish Oils (administration & dosage)
  • Gene Expression
  • Hepatocytes (metabolism)
  • Hyperlipidemias (enzymology, genetics)
  • Insulin (blood)
  • Lipoproteins, VLDL (metabolism)
  • Mice
  • Mice, Knockout
  • Non-alcoholic Fatty Liver Disease
  • Obesity (enzymology, genetics)
  • Phenotype
  • Phospholipids (metabolism)
  • Sterol Regulatory Element Binding Protein 1 (genetics, metabolism)
  • Triglycerides (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: